<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23866694</article-id><article-id pub-id-type="pmc">3723885</article-id><article-id pub-id-type="publisher-id">1476-511X-12-105</article-id><article-id pub-id-type="doi">10.1186/1476-511X-12-105</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Effect of a high bicarbonate mineral water on fasting and postprandial lipemia in moderately hypercholesterolemic subjects: a pilot study</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Zair</surname><given-names>Yassine</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yassine.zair@chu-nantes.fr</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Kasbi-Chadli</surname><given-names>Fatima</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>Fatima.chadli-kasbi@univ-nantes.fr</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Housez</surname><given-names>Beatrice</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>beatrice.housez@biofortis.fr</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Pichelin</surname><given-names>Mathieu</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Matthieu.pichelin@chu-nantes.fr</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Cazaubiel</surname><given-names>Murielle</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>murielle.cazaubiel@biofortis.fr</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Raoux</surname><given-names>Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>multimed@wanadoo.fr</email></contrib><contrib contrib-type="author" corresp="yes" id="A7"><name><surname>Ouguerram</surname><given-names>Khadija</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>khadija.ouguerram@univ-nantes.fr</email></contrib></contrib-group><aff id="I1"><label>1</label>L'Institut du thorax, IRT, 8 quai Moncousu, BP 70721, Nantes Cedex 1 44007, France</aff><aff id="I2"><label>2</label>BIOFORTIS, 3 route de la Chatterie, Saint-Herblain 44800, France</aff><aff id="I3"><label>3</label>Multimed, villa Lantiez, Paris 75017, France</aff><aff id="I4"><label>4</label>CRNH, Human Nutrition Research Center of Nantes, CHU, Nantes F-44093, France</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>18</day><month>7</month><year>2013</year></pub-date><volume>12</volume><fpage>105</fpage><lpage>105</lpage><history><date date-type="received"><day>11</day><month>2</month><year>2013</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Zair et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Zair et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.lipidworld.com/content/12/1/105"/><abstract><sec><title>Background</title><p>During postprandial state, TG concentration is increasing and HDL cholesterol decreasing, leading to a transitory pro-atherosclerotic profile. Previous studies have reported that bicarbonate water improve postprandial lipemia. The objective of this study was to analyze the effect of a strongly bicarbonated mineral water on lipoprotein levels during fasting and postprandial state.</p></sec><sec><title>Methods</title><p>A controlled, randomised, double-blind cross-over design was conducted in 12 moderately hypercholesterolemic subjects after a daily ingestion of 1.25&#x000a0;L of mineral (SY) or low mineral water during eight weeks separated by a one week wash-out period. Blood samples were collected in first visit to the hospital (V1) before water consumption (referent or SY) and in a second visit (V2) after eight week water consumption period. The effect of the consumed water was studied in fasting and in postprandial state during ingestion of a meal and 0.5&#x000a0;L of water.</p></sec><sec><title>Results</title><p>Comparison of data between V1 and V2 after SY consumption showed a significant decrease in triglyceridemia (23%), VLDL TG (31%) and tendency to a decrease of VLDL cholesterol (p&#x02009;=&#x02009;0.066) at fasting state. Whatever the consumed water during postprandial state, the measurement of total areas under curves did not show a significant difference. No difference was observed between SY and referent water consumption for measured parameters at fasting and postprandial state.</p></sec><sec><title>Conclusion</title><p>When subjects consumed SY we showed a decrease of their basal TG and VLDLTG. The unexpected absence of effect of high mineralized water on postprandial lipemia, probably related to experimental conditions, is discussed in the discussion section.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Prolonged postprandial hyperlipidemia constitutes an important cardiovascular risk factor [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. This risk is related to both increased triglyceride (TG)-rich lipoprotein (TRL, chylomicrons, remnant of chylomicrons and VLDL) levels and decreased HDL cholesterol. The decrease of HDL cholesterol often associated with an increased TRL [<xref ref-type="bibr" rid="B3">3</xref>] and is considered as atherogenic [<xref ref-type="bibr" rid="B4">4</xref>] through the implication of these lipoproteins in the transport of excess cholesterol from peripheral tissues to the liver, a process known as reverse cholesterol transport [<xref ref-type="bibr" rid="B5">5</xref>].</p><p>Improving postprandial lipid profile on the basis of reducing TRL and increasing HDL cholesterol is considered as a good strategy to fight the development of cardiovascular disease. Therefore, dietary recommendations advise the reduction of saturated fat consumption to decrease atherogenic lipoproteins in fasting plasma and reduce the risks of cardiovascular disease [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Beverages are essential components of the diet and may also influence the levels plasma lipids. Of note, investigations of mineral waters in animal models presented conflicting [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. A first study reported that, in fasting state, the consumption of Calcium/magnesium rich waters decreased plasma total cholesterol and LDL cholesterol in rat [<xref ref-type="bibr" rid="B9">9</xref>] while another study showed an increase in HDL cholesterol and stabilization of LDL cholesterol in rat fed cholesterol rich diet, with an active conversion of cholesterol into bile acid [<xref ref-type="bibr" rid="B10">10</xref>]. Investigations in human also reported some positive effects of mineral water consumption. Study in human showed also that mineral water decreased total and LDL cholesterol in plasma [<xref ref-type="bibr" rid="B11">11</xref>]. Sulphur water oral administration (Wies&#x00142;aw water, Poland) in patients with atheroslcerosis showed a decrease in total and LDL cholesterol and TG [<xref ref-type="bibr" rid="B12">12</xref>]. Also, in pioneer experiments Capurso <italic>et al</italic>. [<xref ref-type="bibr" rid="B13">13</xref>] have shown that the mineral bicarbonated water (Montecatini, Italy) presented decreasing effect on total and LDL cholesterol in fasting state. Similar effects have been reported for bicarbonated water from another source (Vichy Catalan, Spain) [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. This justifies recommendation of such waters in hypercholesterolemia. However, the compositions of minerals in the carbonated waters used in these studies were not comparable and in some case not fully known [<xref ref-type="bibr" rid="B17">17</xref>], preventing generalization for the use of bicarbonated mineral waters. Moreover, most of these studies were interested by the changes induced by mineral waters on LDL cholesterol, while the effects on TG and HDL of hypercholesterolemic subjects were inconsistently shown [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Of note, Schoppen et al. [<xref ref-type="bibr" rid="B16">16</xref>] reported a reduced postprandial lipemia in healthy postmenoposal women with mineral water rich in bicarbonate probably related to an increase of intestinal pH which is known to affect lipid absorption [<xref ref-type="bibr" rid="B18">18</xref>]. Improvement of postprandial lipemia was also reported in healthy normocholesterolemic young subjects, and the effect was linked to a decrease in cholescystokinin (CCK) level [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p><p>Moreover, mineral carbonated waters present very variable composition in total mineralization and precise ionic profile [<xref ref-type="bibr" rid="B17">17</xref>], preventing generalization for the use of bicarbonated mineral waters.</p><p>Based on this background we investigated the effect of strongly mineralized bicarbonate water (Saint-Yore, France) in both fasting and postprandial state on TG and cholesterol lipoprotein profile.</p></sec><sec sec-type="methods"><title>Subjects and methods</title><p>The experimental protocol was approved by the Ethical Committee of Nantes (CPP Ouest IV) and performed in accordance with Helsinki Declaration of 1975, as revised in 1983. Each subject received a complete explanation of the investigation and gave an informed written consent before the beginning of the study. No subject withdrew during the study.</p><sec><title>Subjects</title><p>Twelve men aged 20&#x02013;60&#x000a0;years, with BMI 18.5 to 25&#x000a0;kg/m<sup>2</sup> and diagnosed with moderate hypercholesterolemia (from 2.20 to 3&#x000a0;g/L) participated in the study. A medical history, a physical examination and a routine laboratory blood screening (glucose, cholesterol, TG, transaminases, creatinine levels, thyroid function and renal clearance) were performed before inclusion. Subjects suffering from type 2 diabetes, transit or metabolic disorders or high blood pressure or treated with hypolipidemic drugs were excluded. The participants were instructed not to deviate from their regular habits during the study.</p><p>To assess average food intakes during the study, a food-frequency questionnaire was administered to the participants. Participants are also given a questionnaire and a list of all aliments and asked to note precisely each aliment and the amount consumed for 3&#x000a0;days. Analysis of the questionnaire data by dietitian provided estimates of consumption frequency and the nutrients composition of meals for 3&#x000a0;days per week (two days from Monday to Friday and one day in the week-end) during the eight weeks of each period. Thus, the background diets provided 15% of energy from proteins, 50% of energy from carbohydrates, and 35% of energy from fat.</p></sec><sec><title>Experimental protocol</title><p>The study was conducted according to a controlled, randomised, double-blind cross-over design with two 8-week experimental periods separated by a 1-week wash-out period.</p><p>During the experimental periods, subjects had to consume daily 1.25&#x000a0;L of one of the 2 tested sparkling waters: Saint-Yorre (SY) or Ogeu (referent). SY water is characterized by a high mineral content unlike referent water (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Subjects were randomly assigned to one of the two sequences of product consumption (SY/referent or referent/SY) following their inclusion in the study.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Mineral content of the studied waters: units mg/L (mmoles/L in brackets)</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Mineral content</bold><hr/></th><th align="left" valign="bottom"><bold>SY</bold><hr/></th><th align="left" valign="bottom"><bold>Referent</bold><hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>water</bold></th><th align="left"><bold>water</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Bicarbonates<hr/></td><td align="left" valign="bottom">4168 (68.3)<hr/></td><td align="left" valign="bottom">183 (3.0)<hr/></td></tr><tr><td align="left" valign="bottom">Chlorides<hr/></td><td align="left" valign="bottom">329 (9.3)<hr/></td><td align="left" valign="bottom">48 (1.4)<hr/></td></tr><tr><td align="left" valign="bottom">Sulfates<hr/></td><td align="left" valign="bottom">186 (1.9)<hr/></td><td align="left" valign="bottom">18 (0.2)<hr/></td></tr><tr><td align="left" valign="bottom">Calcium<hr/></td><td align="left" valign="bottom">85 (2.1)<hr/></td><td align="left" valign="bottom">48 (1.2)<hr/></td></tr><tr><td align="left" valign="bottom">Magnesium<hr/></td><td align="left" valign="bottom">11 (0.4)<hr/></td><td align="left" valign="bottom">12 (0.5)<hr/></td></tr><tr><td align="left" valign="bottom">Sodium<hr/></td><td align="left" valign="bottom">1626 (70.7)<hr/></td><td align="left" valign="bottom">31 (1.3)<hr/></td></tr><tr><td align="left" valign="bottom">Potassium<hr/></td><td align="left" valign="bottom">117 (3.0)<hr/></td><td align="left" valign="bottom">1 (0.02)<hr/></td></tr><tr><td align="left">Nitrates</td><td align="left">2 (0.03)</td><td align="left">5 (0.08)</td></tr></tbody></table></table-wrap><p>Five visits were planned at the clinical center for each subject: the pre-inclusion visit (V0), at the beginning of the experimental periods (V1) and on the last day of the experimental periods (V2). The baseline characteristics of study participant are shown in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Baseline characteristics of study participants</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left"><bold>Mean (SD)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Age (years)<hr/></td><td align="left" valign="bottom">40.6 (&#x000b1; 9.4)<hr/></td></tr><tr><td align="left" valign="bottom">Height (cm)<hr/></td><td align="left" valign="bottom">175.1 (&#x000b1; 5.8)<hr/></td></tr><tr><td align="left" valign="bottom">Body mass index (kg/m<sup>2</sup>)<hr/></td><td align="left" valign="bottom">23.1 (&#x000b1; 2.2)<hr/></td></tr><tr><td align="left" valign="bottom">Glucose (g/L)<hr/></td><td align="left" valign="bottom">0.948 (&#x000b1; 0.074)<hr/></td></tr><tr><td align="left" valign="bottom">Plasma cholesterol (g/L)<hr/></td><td align="left" valign="bottom">2.434 (&#x000b1; 0.213)<hr/></td></tr><tr><td align="left" valign="bottom">LDL cholesterol (g/L)<hr/></td><td align="left" valign="bottom">1.29 (&#x000b1;0.20)<hr/></td></tr><tr><td align="left" valign="bottom">Plasma triglycerides (g/L)<hr/></td><td align="left" valign="bottom">0.970 (&#x000b1;0.317)<hr/></td></tr><tr><td align="left" valign="bottom">Systolic blood pressure (mmHg)<hr/></td><td align="left" valign="bottom">119.8 (&#x000b1; 13.3)<hr/></td></tr><tr><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">79.7 (&#x000b1; 13.6)</td></tr></tbody></table><table-wrap-foot><p>Mean&#x000b1;SD, n=12.</p></table-wrap-foot></table-wrap><p>Experimental sessions were performed on V1 and V2 of both periods. On each occasion, fasted subjects came to the clinical center in the morning. After medical examination, an intravenous catheter was inserted into an arm vein and a first blood sample was collected (T0). Then, the subject consumed a standardised meal (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). This meal provided 798 Kcal and constituted with 37.7&#x000a0;g of fat, 89.20&#x000a0;g of carbohydrate and 25.72&#x000a0;g of protein with 0.5&#x000a0;L of the sparkling water prescribed during the experimental period in progress. Additional blood samples were obtained at T30min, T1h, T2h, T3h, T4h, T6h and T8h to determine the total area under curve (TAUC). Subjects were instructed not to eat or drink anything else during the 8-h experimental session.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>The composition of standard meal given during postprandial test</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left"><bold>Amount (g)</bold></th><th align="left"><bold>Proteins (g)</bold></th><th align="left"><bold>Carbohydrates (g)</bold></th><th align="left"><bold>Lipids (g)</bold></th><th align="left"><bold>Energy (Kcal)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Butter<hr/></td><td align="left" valign="bottom">20<hr/></td><td align="left" valign="bottom">0.14<hr/></td><td align="left" valign="bottom">0.08<hr/></td><td align="left" valign="bottom">16.6<hr/></td><td align="left" valign="bottom">150.28<hr/></td></tr><tr><td align="left" valign="bottom">Cheese<hr/></td><td align="left" valign="bottom">60<hr/></td><td align="left" valign="bottom">17.64<hr/></td><td align="left" valign="bottom">0.12<hr/></td><td align="left" valign="bottom">17.28<hr/></td><td align="left" valign="bottom">226.56<hr/></td></tr><tr><td align="left" valign="bottom">stewed apricot<hr/></td><td align="left" valign="bottom">220<hr/></td><td align="left" valign="bottom">1.54<hr/></td><td align="left" valign="bottom">50.6<hr/></td><td align="left" valign="bottom">0.22<hr/></td><td align="left" valign="bottom">210.54<hr/></td></tr><tr><td align="left" valign="bottom">white bread<hr/></td><td align="left" valign="bottom">80<hr/></td><td align="left" valign="bottom">6.4<hr/></td><td align="left" valign="bottom">38.4<hr/></td><td align="left" valign="bottom">3.6<hr/></td><td align="left" valign="bottom">211.6<hr/></td></tr><tr><td align="left" valign="bottom">energy (Kcal)<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">102.88<hr/></td><td align="left" valign="bottom">356.8<hr/></td><td align="left" valign="bottom">339.3<hr/></td><td align="left" valign="bottom">798.98<hr/></td></tr><tr><td align="left">% of total energy</td><td align="left">&#x000a0;</td><td align="left">12.88</td><td align="left">44.66</td><td align="left">42.47</td><td align="left">100</td></tr></tbody></table></table-wrap></sec><sec><title>Data collection</title><p>Data were analyzed at T0 (chronic effect of water consumption) and as area under the curve (acute effect of water consumption) for plasma (cholesterol, TG, glucose and insulin), apolipoprotein A1 in HDL and free cholesterol, cholesteryl ester, total cholesterol and TG in all the lipoproteins.</p><p>Before starting blood pressure assessment, the healthy subjects had to rest in a horizontal position for 15&#x000a0;minutes. A blood pressure cuff was applied on the contra lateral upper arm.</p></sec><sec><title>Biochemical analysis</title><p>Blood was collected into tubes containing EDTA for determination of all lipid parameters. For glucose measurement blood was collected into tubes containing fluoride which inhibit glycolytic pathway [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Total cholesterol, unesterified cholesterol, cholesteryl ester, TG and glycemia were assayed by enzymatic colorimetric test with Hitachi 911; insulinemia by ELISA (DakoCytomation Insulin kit); and A1 by immunoturbidimetric assay with Hitachi 911.</p><sec><title>Lipoprotein separation</title><p>Isolation of lipoproteins was undertaken by using ultracentrifugation (CO-LE80K, rotor 50.4 TI; Beckman Coulter Inc., Brea, CA, USA). After overlaying 2&#x000a0;mL of serum with 4&#x000a0;mL of NaCl solution with a density of 1.006 and centrifuged for 23&#x000a0;minutes at 19040&#x000a0;g and 10&#x000b0;C, the chylomicrons were first isolated from the meniscus of the tube. The lower layer was overlaid with 2&#x000a0;mL of NaCl solution with a density of 1.006 and centrifuged for 18&#x000a0;hours at 246758&#x000a0;g and 10&#x000b0;C to obtain VLDL fraction. After removal of the supernatant, LDL (1.020&#x02009;&#x0003c;&#x02009;d &#x0003c;1.063) and HDL (1.020&#x02009;&#x0003c;&#x02009;d &#x0003c;1.063&#x000a0;g/mL) were respectively separated by standard sequential ultracentrifugation methods [<xref ref-type="bibr" rid="B22">22</xref>].</p></sec></sec><sec><title>Statistical analysis</title><p>A statistical power of 80% was calculated for 10 participants. The results are expressed as means&#x02009;&#x000b1;&#x02009;SDs from all 12 participants. The postprandial response of all measured parameters was calculated as total area under the curve, ie, the total increase above zero data for 480&#x000a0;min.</p><p>Considering chronic effect, quantitative data of all parameters were performed by repeated measures of ANOVA with fixed factors &#x0201c;product&#x0201d;, &#x0201c;period&#x0201d;, &#x0201c;subject&#x0201d; and baseline. Considering acute effect, quantitative data for all parameters were performed by repeated measures of ANOVA on TAUC with fixed factors &#x0201c;product&#x0201d;, &#x0201c;period&#x0201d; and &#x0201c;subject&#x0201d;.</p><p>The statistical analyses were performed with the use of SAS 9.1.3 Service Pack 4 software (SAS institute, Cary, NC, USA). Data are considered significant when p was less than 0.05.</p><p>Whenever data were not normally distributed, as for plasma and VLDL TG, a log transformation was applied before statistical analysis.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Water composition</title><p>SY and referent water composition are presented in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>: Compared to referent water, SY water is very mineralized (20 fold more: 79 versus 4&#x000a0;mmol/L) and is essentially richer in bicarbonates (25 fold), sodium (50 fold) and potassium (120 fold). Chlorides, sulfates and calcium content is respectively higher by 7, 10 and 2 fold in SY than referent water.</p></sec><sec><title>Baseline characteristics of study participants</title><p>There were no significant differences in anthropometric data between the subjects of the two sequences of water consumption (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). After the washout period the baseline values were not different for all parameters.</p></sec><sec><title>The comparison between the two waters</title><p>Statistical analysis showed no difference for all the measured parameters between the two waters (Tables&#x000a0;<xref ref-type="table" rid="T4">4</xref> and <xref ref-type="table" rid="T5">5</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Glycemia, blood pressure, plasma and VLDL TG and total, VLDL, HDL and LDL cholesterol levels in fasting state (g/L) at V1 and V2 in participants after consumption of referent or SY water</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left">&#x000a0;</th><th align="left">&#x000a0;</th><th align="left"><bold>V1 (n = 12)</bold></th><th align="left"><bold>V2 (n = 12)</bold></th><th align="left"><bold>p-value</bold></th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="top">glycemia g/L<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">0.928&#x02009;&#x000b1;&#x02009;0.064<hr/></td><td align="left" valign="bottom">0.908&#x02009;&#x000b1;&#x02009;0.059<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">0.968&#x02009;&#x000b1;&#x02009;0.085<hr/></td><td align="left" valign="bottom">0.931&#x02009;&#x000b1;&#x02009;0.067<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="4" align="left" valign="top">blood pressure (mmHg)<hr/></td><td rowspan="2" align="left" valign="top">Systolic<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">121.6&#x02009;&#x000b1;&#x02009;17.6<hr/></td><td align="left" valign="bottom">129.8&#x02009;&#x000b1;&#x02009;8.2<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">119.8&#x02009;&#x000b1;&#x02009;13.3<hr/></td><td align="left" valign="bottom">121.8&#x02009;&#x000b1;&#x02009;10.0<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">Diastolic<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">73.2&#x02009;&#x000b1;&#x02009;14.8<hr/></td><td align="left" valign="bottom">77.5&#x02009;&#x000b1;&#x02009;9.0<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">79.7&#x02009;&#x000b1;&#x02009;13.6<hr/></td><td align="left" valign="bottom">75.9&#x02009;&#x000b1;&#x02009;9.9<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">Plasma TG (g/L)<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">1.217&#x02009;&#x000b1;&#x02009;0.536<hr/></td><td align="left" valign="bottom">0.940&#x02009;&#x000b1;&#x02009;0.492<hr/></td><td align="left" valign="bottom">p&#x02009;&#x0003c;&#x02009;0.01<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">1.12&#x02009;&#x000b1;&#x02009;0.59<hr/></td><td align="left" valign="bottom">1.01&#x02009;&#x000b1;&#x02009;0.38<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">plasma cholesterol (g/L)<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">2.39&#x02009;&#x000b1;&#x02009;0.26<hr/></td><td align="left" valign="bottom">2.35&#x02009;&#x000b1;&#x02009;0.20<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">2.22&#x02009;&#x000b1;&#x02009;0.0.35<hr/></td><td align="left" valign="bottom">2.32&#x02009;&#x000b1;&#x02009;0.25<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">VLDL TG (g/L)<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">0.767&#x02009;&#x000b1;&#x02009;0.347<hr/></td><td align="left" valign="bottom">0.529&#x02009;&#x000b1;&#x02009;0.355<hr/></td><td align="left" valign="bottom">p&#x02009;&#x0003c;&#x02009;0.01<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">0.670&#x02009;&#x000b1;&#x02009;0.427<hr/></td><td align="left" valign="bottom">0.619&#x02009;&#x000b1;&#x02009;0.289<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">VLDL cholesterol (g/L)<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">0.353&#x02009;&#x000b1;&#x02009;0.103<hr/></td><td align="left" valign="bottom">0.298&#x02009;&#x000b1;&#x02009;0.100<hr/></td><td align="left" valign="bottom">p&#x02009;=&#x02009;0.066<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">0.338&#x02009;&#x000b1;&#x02009;0.160<hr/></td><td align="left" valign="bottom">0.318&#x02009;&#x000b1;&#x02009;0.090<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">HDL cholesterol (g/L)<hr/></td><td rowspan="2" align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">0.414&#x02009;&#x000b1;&#x02009;0.105<hr/></td><td align="left" valign="bottom">0.460&#x02009;&#x000b1;&#x02009;0.124<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">0.425&#x02009;&#x000b1;&#x02009;0.159<hr/></td><td align="left" valign="bottom">0.445&#x02009;&#x000b1;&#x02009;0.128<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="top">LDL cholesterol (g/L)<hr/></td><td align="left" valign="top">T0<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">1.282&#x02009;&#x000b1;&#x02009;0.172<hr/></td><td align="left" valign="bottom">1.339&#x02009;&#x000b1;&#x02009;0.184<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Referent</td><td align="left">1.290&#x02009;&#x000b1;&#x02009;0.201</td><td align="left">1.277&#x02009;&#x000b1;&#x02009;0.199</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p>Mean&#x000b1;SD, n=12.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Total area under the curve for glugose, plasma and VLDL TG, VLDL, HDL and LDL cholesterol during postprandial state at V1 and V2 in participants after consumption of referent or SY water</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left">&#x000a0;</th><th align="left"><bold>V1 (n = 12)</bold></th><th align="left"><bold>V2 (n = 12)</bold></th><th align="left"><bold>p-value</bold></th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="top">Glycemia (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">428.93&#x02009;&#x000b1;&#x02009;28.69<hr/></td><td align="left" valign="bottom">440.37&#x02009;&#x000b1;&#x02009;25.64<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">423.59&#x02009;&#x000b1;&#x02009;25.05<hr/></td><td align="left" valign="bottom">432.83&#x02009;&#x000b1;&#x02009;27.58<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">Plasma TG (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">839.08&#x02009;&#x000b1;&#x02009;397.06<hr/></td><td align="left" valign="bottom">637.43&#x02009;&#x000b1;&#x02009;317.36<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">781.66&#x02009;&#x000b1;&#x02009;362.94<hr/></td><td align="left" valign="bottom">679.03&#x02009;&#x000b1;&#x02009;250.25<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">VLDL TG (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">487.14&#x02009;&#x000b1;&#x02009;233.33<hr/></td><td align="left" valign="bottom">383.39&#x02009;&#x000b1;&#x02009;219.80<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">480.55&#x02009;&#x000b1;&#x02009;252.15<hr/></td><td align="left" valign="bottom">419.15 &#x000b1;165.28<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">VLDL cholesterol (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">171.99&#x02009;&#x000b1;&#x02009;57.77<hr/></td><td align="left" valign="bottom">163.59&#x02009;&#x000b1;&#x02009;46.04<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">167.28&#x02009;&#x000b1;&#x02009;60.39<hr/></td><td align="left" valign="bottom">171.47&#x02009;&#x000b1;&#x02009;47.67<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td rowspan="2" align="left" valign="top">HDL cholesterol (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">192.41&#x02009;&#x000b1;&#x02009;50.31<hr/></td><td align="left" valign="bottom">217.38&#x02009;&#x000b1;&#x02009;59.41<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="bottom">Referent<hr/></td><td align="left" valign="bottom">200.54&#x02009;&#x000b1;&#x02009;66.87<hr/></td><td align="left" valign="bottom">213.50&#x02009;&#x000b1;&#x02009;67.47<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left" valign="top">LDL cholesterol (g/L.min)<hr/></td><td align="left" valign="bottom">SY<hr/></td><td align="left" valign="bottom">604.56&#x02009;&#x000b1;&#x02009;70.14<hr/></td><td align="left" valign="bottom">634.28&#x02009;&#x000b1;&#x02009;85.18<hr/></td><td align="left" valign="bottom">NS<hr/></td></tr><tr><td align="left">&#x000a0;</td><td align="left">Referent</td><td align="left">620.03&#x02009;&#x000b1;&#x02009;111.59</td><td align="left">604.67&#x02009;&#x000b1;&#x02009;69.00</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p>(TAUC<sub>T0-480</sub>(g/L.min)), mean&#x000b1;SD, n=12.</p></table-wrap-foot></table-wrap><p>No significant variation was reported on arterial tension (systolic and diastolic blood pressure, considering SY or referent waters consumption in basal or postprandial state (Tables&#x000a0;<xref ref-type="table" rid="T4">4</xref> and <xref ref-type="table" rid="T5">5</xref>).</p><p>Glycemia, blood pressure, TG and cholesterol concentrations in plasma and lipoprotein at baseline (T0) and in postprandial state (TAUC<sub>T0-T8h</sub>) are presented in Table&#x000a0;<xref ref-type="table" rid="T4">4</xref> and Table&#x000a0;<xref ref-type="table" rid="T5">5</xref> respectively for subjects before and after SY or referent water consumption. No significant effect was shown when subjects consumed the low-mineralized referent water.</p></sec><sec><title>Effect of SY water on lipid parameters</title><p>At fasting state, when subjects ingested SY water, we observed a significant decrease in plasma TG (23%, p&#x02009;&#x0003c;&#x02009;0.01) and in VLDL TG (31%, p&#x02009;&#x0003c;&#x02009;0&#x02022;01) and a tendency to a decrease of VLDL cholesterol (16%, p&#x02009;=&#x02009;0.066) (Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>).</p><p>At postprandial state, the results showed no significant difference neither for plasma and VLDL TG nor for VLDL, LDL and HDL cholesterol (Table&#x000a0;<xref ref-type="table" rid="T5">5</xref>).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Although, no difference was observed between the two waters in this pilot study, we showed that the consumption of high mineral water (SY) during eight weeks in moderated hypercholesterolemic subject induced a decrease in plasma and VLDL TG and tended to decrease VLDL cholesterol. This high mineral water did not affect lipids parameters at postprandial state.</p><p>In our study, no change in blood pressure was observed. Hypertensive effect of sodium has been noted when accompanied by chloride but not by bicarbonate [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. This explains that, although mineralized water of our study provided 2 grams per day of sodium, no change in blood pressure was noted as this water provided 5&#x000a0;g of bicarbonate but only 0.4&#x000a0;g of chloride.</p><p>At the postprandial state, plasma TG, VLDL TG and chylomicron TG concentrations were not affected by water consumption (referent or SY). In contrast to our study, previous data, from the same team, reported an improvement of lipidic charge in postprandial state by water rich in bicarbonate [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. The absence of effect of bicarnonated water on postprandial lipemia in our study was unexpected and could be explained by the lower energetic meal provided in our study (1089 Kcal in the two studies vs 799 Kcal in ours). Although we have used a meal rich in fat (42% VS 36%) to stimulate postprandial lipemia, this lipidic charge was not sufficient to induce a higher postprandial triglyceridemia. In fact, the elevated TG that we measured during postprandial test, whatever the water consumed, is lower than what is classically reported [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Studies investigating postprandial lipemia provided more than 1000 Kcal and at least 60% of calories from fat [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Thus we suppose that the increase of lipidic charge in postprandial test could induce a significant hypertriglyceridemia during meal absorption and higher probability to measure a bicarbinated water effect. Moreover a strong association has been reported between postprandial triglyceridemia and early atherosclerosis markers [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B28">28</xref>] which suppose that fasting triglyceridemia is tightly dependent on the postprandial lipemia. Indeed, as soon as 1979, Zilversmit proposed that atherosclerosis was a postprandial phenomenon [<xref ref-type="bibr" rid="B29">29</xref>].</p><p>In the present study SY chronic ingestion induced a decrease in plasma TG related to a diminution of VLDL TG. We also reported a tendency to decrease VLDL cholesterol. The improvement of plasma lipid and cardiovascular risk by chronic ingestion of a high bicarbonate water was also reported by other studies [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>] with differential effect on lipoproteins. Some studies reported a decrease in LDL cholesterol [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>] and others showed a decrease in LDL cholesterol associated with an increase in HDL cholesterol [<xref ref-type="bibr" rid="B15">15</xref>] were reported. In this series of experiments, effect on TG was observed only in postprandial state while no change was observed in fasting state. One probable mechanism that could explain the decrease of VLDL TG in our work is a postprandial lipemia effect, although not observed in our study. As discussed higher a strong association has been reported between postprandial triglyceridemia and fasting lipid levels [<xref ref-type="bibr" rid="B30">30</xref>]. In fact, intestine derived lipids during absorption modulates liver VLDL synthesis and secretion which could affect triglyceridemia measured in fasting state [<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B33">33</xref>].</p><p>These different results showing effect on cholesterol in almost studies [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>] and on triglycerides in our case, could be related to the mineral composition of used waters. SY water is characterized by, a higher mineralization compared to the others studies and among anions a higher concentration in bicarbonate and almost a lower one in chloride. SY is water richer in bicarbonated (4167&#x000a0;mg/L) and less rich in chloride (329&#x000a0;mg/L) and contains a very high molar ratio HCO3/Cl (7.3). We did not observe any effect on LDL cholesterol, potentially described as bile acid dependent [<xref ref-type="bibr" rid="B13">13</xref>] but we observed an effect on plasma and VLDL TG. Effect on plasma cholesterol and bile acid excretion has been initially observed in the pioneer study of Capurso <italic>et al</italic>., [<xref ref-type="bibr" rid="B13">13</xref>]. In this later study, authors have used Montecatini water witch correspond to a low bicarbonate (677&#x000a0;mg/L) and low chloride content (922&#x000a0;mg/L) and then a very low molar ratio HCO<sub>3</sub>/Cl (0.43). The same effect was recovered in the studies of Vaquero&#x02019;s laboratory [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>] using a water (Vichy-Catalan) more bicarbonated (2094&#x000a0;mg/L) but even rich in chloride (583&#x000a0;mg/L) and then an intermediate molar ratio HCO<sub>3</sub>/Cl (2.1). It is well known that chloride and bicarbonate have differential effects on vascular parameters [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. It has been also shown that a high concentration of NaCl increased gallbladder motility [<xref ref-type="bibr" rid="B35">35</xref>] that could be related to bile acid excretion. Thus it could be credible to hypothesize that bicarbonated waters with a high Cl/HCO<sub>3</sub> ratio could affect plasma cholesterol by the stimulation of bile acid excretion, while water with low Cl/HCO<sub>3</sub> ratio affect mainly TG concentration by affecting intestinal absorption.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In conclusion, although this study did not show any difference between the two waters, data comparison before and after sodium bicarbonated mineral consumption showed a specific decrease in plasma and VLDL TG at basal state. Unfortunately we measured no effect on lipid kinetics during postprandial phase probably due to our meal test that was not rich enough in lipids. Originality of the effects observed in lipid parameters by SY water used in our study could be related to its specific mineral composition (high mineralization with high bicarbonate concentration and low chloride concentration). These promising results raised a number of questions debated in the manuscript which could be confirmed by future study with a larger number of subjects presenting elevated triglyceridemia as in particular metabolic syndrome patient.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>YZ contributed to the conception and the design of study and conducted the clinical trial; Biofortis provided technical assistance; KO conceived the study, participated in the design and wrote the first version of manuscript. BH and FKC participated to the manuscript writing and revision, MP: study coordinator. All authors have contributed to the revision of the submitted manuscript and agreed with this version.</p></sec></body><back><sec><title>Acknowledgements</title><p>All authors have contributed to the preparation of the manuscript and agree with the submitted manuscript content. This work was supported by Neptune society.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>De Man</surname><given-names>FH</given-names></name><name><surname>Cabezas</surname><given-names>MC</given-names></name><name><surname>Van Barlingen</surname><given-names>HH</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name><name><surname>de Bruin</surname><given-names>TW</given-names></name><article-title>Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis</article-title><source>Eur J Clin Invest</source><year>1996</year><volume>26</volume><fpage>89</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2362.1996.114256.x</pub-id><pub-id pub-id-type="pmid">8904518</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Steiner</surname><given-names>G</given-names></name><name><surname>Uffelman</surname><given-names>K</given-names></name><name><surname>Olivecrona</surname><given-names>T</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><article-title>Postprandial lipoproteins and progression of coronary atherosclerosis</article-title><source>Atherosclerosis</source><year>1994</year><volume>106</volume><fpage>83</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/0021-9150(94)90085-X</pub-id><pub-id pub-id-type="pmid">8018110</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Patsch</surname><given-names>JR</given-names></name><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Gotto</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Bengtsson-Olivecrona</surname><given-names>G</given-names></name><article-title>Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase</article-title><source>J Clin Invest</source><year>1984</year><volume>74</volume><fpage>2017</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1172/JCI111624</pub-id><pub-id pub-id-type="pmid">6439739</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Gotto</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Brinton</surname><given-names>EA</given-names></name><article-title>Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>43</volume><fpage>717</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2003.08.061</pub-id><pub-id pub-id-type="pmid">14998606</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Fielding</surname><given-names>CJ</given-names></name><name><surname>Fielding</surname><given-names>PE</given-names></name><article-title>Molecular physiology of reverse cholesterol transport</article-title><source>J Lipid Res</source><year>1995</year><volume>36</volume><fpage>211</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">7751809</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Howell</surname><given-names>WH</given-names></name><name><surname>McNamara</surname><given-names>DJ</given-names></name><name><surname>Tosca</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>BT</given-names></name><name><surname>Gaines</surname><given-names>JA</given-names></name><article-title>Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis</article-title><source>Am J Clin Nutr</source><year>1997</year><volume>65</volume><fpage>1747</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">9174470</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>BH</given-names></name><name><surname>Cho</surname><given-names>BH</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Doran</surname><given-names>S</given-names></name><name><surname>Osterlund</surname><given-names>L</given-names></name><etal/><article-title>Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>1145</fpage><lpage>1158</lpage><pub-id pub-id-type="pmid">15531660</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Bobon</surname><given-names>D</given-names></name><name><surname>Troisfontaines</surname><given-names>B</given-names></name><name><surname>Kempeneers</surname><given-names>JL</given-names></name><name><surname>Xhenseval</surname><given-names>B</given-names></name><name><surname>Bourdouxhe</surname><given-names>S</given-names></name><etal/><article-title>Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales</article-title><source>Acta Psychiatr Belg</source><year>1986</year><volume>86</volume><fpage>152</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">2873713</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Nasuti</surname><given-names>C</given-names></name><name><surname>Gabbianelli</surname><given-names>R</given-names></name><name><surname>Cantalamessa</surname><given-names>F</given-names></name><name><surname>Falcioni</surname><given-names>G</given-names></name><article-title>Erythrocyte plasma membrane perturbations in rats fed a cholesterol-rich diet: effect of drinking sulphurous mineral water</article-title><source>Ann Nutr Metab</source><year>2005</year><volume>49</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1159/000084172</pub-id><pub-id pub-id-type="pmid">15735363</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Toussaint</surname><given-names>C</given-names></name><name><surname>Peuchant</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>BC</given-names></name><name><surname>Jensen</surname><given-names>R</given-names></name><name><surname>Canellas</surname><given-names>J</given-names></name><article-title>Influence of calcic and magnesic sulphurous thermal water on the metabolism of lipoproteins in the rat</article-title><source>Arch Int Physiol Biochim</source><year>1986</year><volume>94</volume><fpage>65</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.3109/13813458609071403</pub-id><pub-id pub-id-type="pmid">2430538</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Nerbrand</surname><given-names>C</given-names></name><name><surname>Agreus</surname><given-names>L</given-names></name><name><surname>Lenner</surname><given-names>RA</given-names></name><name><surname>Nyberg</surname><given-names>P</given-names></name><name><surname>Svardsudd</surname><given-names>K</given-names></name><article-title>The influence of calcium and magnesium in drinking water and diet on cardiovascular risk factors in individuals living in hard and soft water areas with differences in cardiovascular mortality</article-title><source>BMC Public Health</source><year>2003</year><volume>3</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-3-21</pub-id><pub-id pub-id-type="pmid">12814520</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Goszcz</surname><given-names>A</given-names></name><name><surname>Kostka-Trabka</surname><given-names>E</given-names></name><name><surname>Grodzinska</surname><given-names>L</given-names></name><name><surname>Slawinski</surname><given-names>M</given-names></name><name><surname>Bieron</surname><given-names>K</given-names></name><etal/><article-title>The effect of treatment with sulphur water from the spring in wieslaw in busko-solec on levels of lipids, the fibrinolytic system and thrombogenic platelet function in patients with arteriosclerosis</article-title><source>Pol Merkur Lekarski</source><year>1997</year><volume>3</volume><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9432299</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Capurso</surname><given-names>A</given-names></name><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>Panza</surname><given-names>F</given-names></name><name><surname>Mastroianni</surname><given-names>F</given-names></name><name><surname>Torres</surname><given-names>F</given-names></name><etal/><article-title>Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water</article-title><source>Aging (Milano)</source><year>1999</year><volume>11</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">10605616</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Perez-Granados</surname><given-names>AM</given-names></name><name><surname>Navas-Carretero</surname><given-names>S</given-names></name><name><surname>Schoppen</surname><given-names>S</given-names></name><name><surname>Vaquero</surname><given-names>MP</given-names></name><article-title>Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults</article-title><source>J Nutr Biochem</source><year>2010</year><volume>21</volume><fpage>948</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.07.010</pub-id><pub-id pub-id-type="pmid">19954956</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Schoppen</surname><given-names>S</given-names></name><name><surname>Perez-Granados</surname><given-names>AM</given-names></name><name><surname>Carbajal</surname><given-names>A</given-names></name><name><surname>Oubina</surname><given-names>P</given-names></name><name><surname>Sanchez-Muniz</surname><given-names>FJ</given-names></name><etal/><article-title>A sodium-rich carbonated mineral water reduces cardiovascular risk in postmenopausal women</article-title><source>J Nutr</source><year>2004</year><volume>134</volume><fpage>1058</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">15113945</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Schoppen</surname><given-names>S</given-names></name><name><surname>Perez-Granados</surname><given-names>AM</given-names></name><name><surname>Carbajal</surname><given-names>A</given-names></name><name><surname>Sarria</surname><given-names>B</given-names></name><name><surname>Sanchez-Muniz</surname><given-names>FJ</given-names></name><etal/><article-title>Sodium bicarbonated mineral water decreases postprandial lipaemia in postmenopausal women compared to a low mineral water</article-title><source>Br J Nutr</source><year>2005</year><volume>94</volume><fpage>582</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1079/BJN20051515</pub-id><pub-id pub-id-type="pmid">16197584</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Albertini</surname><given-names>MCD</given-names></name><name><surname>Dacha</surname><given-names>M</given-names></name><name><surname>Teodori</surname><given-names>L</given-names></name><name><surname>Conti</surname><given-names>ME</given-names></name><article-title>Drinking mineral waters: biochemical effets and health implication - state-of-the-art</article-title><source>Int J Environmental Health</source><year>2007</year><volume>1</volume><fpage>153</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1504/IJENVH.2007.012230</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Chijiiwa</surname><given-names>K</given-names></name><name><surname>Linscheer</surname><given-names>WG</given-names></name><article-title>Effect of intraluminal pH on cholesterol and oleic acid absorption from micellar solutions in the rat</article-title><source>Am J Physiol</source><year>1984</year><volume>246</volume><fpage>G492</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">6720950</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Toxqui</surname><given-names>L</given-names></name><name><surname>Perez-Granados</surname><given-names>AM</given-names></name><name><surname>Blanco-Rojo</surname><given-names>R</given-names></name><name><surname>Vaquero</surname><given-names>MP</given-names></name><article-title>A sodium-bicarbonated mineral water reduces gallbladder emptying and postprandial lipaemia: a randomised four-way crossover study</article-title><source>Eur J Nutr</source><year>2012</year><volume>51</volume><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1007/s00394-011-0244-x</pub-id><pub-id pub-id-type="pmid">21913027</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Bertoni</surname><given-names>M</given-names></name><name><surname>Olivieri</surname><given-names>F</given-names></name><name><surname>Manghetti</surname><given-names>M</given-names></name><name><surname>Boccolini</surname><given-names>E</given-names></name><name><surname>Bellomini</surname><given-names>MG</given-names></name><etal/><article-title>Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study</article-title><source>Pharmacol Res</source><year>2002</year><volume>46</volume><fpage>525</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1016/S1043661802002323</pub-id><pub-id pub-id-type="pmid">12457626</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Mikesh</surname><given-names>LM</given-names></name><name><surname>Bruns</surname><given-names>DE</given-names></name><article-title>Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis</article-title><source>Clin Chem</source><year>2008</year><volume>54</volume><fpage>930</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2007.102160</pub-id><pub-id pub-id-type="pmid">18443184</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Ouguerram</surname><given-names>K</given-names></name><name><surname>Krempf</surname><given-names>M</given-names></name><name><surname>Maugeais</surname><given-names>C</given-names></name><name><surname>Maugere</surname><given-names>P</given-names></name><name><surname>Darmaun</surname><given-names>D</given-names></name><etal/><article-title>A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans</article-title><source>Metabolism</source><year>2002</year><volume>51</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11782865</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Boegehold</surname><given-names>MA</given-names></name><name><surname>Kotchen</surname><given-names>TA</given-names></name><article-title>Importance of dietary chloride for salt sensitivity of blood pressure</article-title><source>Hypertension</source><year>1991</year><volume>17</volume><fpage>I158</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.17.1_Suppl.I158</pub-id><pub-id pub-id-type="pmid">1986995</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Schorr</surname><given-names>U</given-names></name><name><surname>Distler</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>AM</given-names></name><article-title>Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial</article-title><source>J Hypertens</source><year>1996</year><volume>14</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">12013486</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Ziomber</surname><given-names>A</given-names></name><name><surname>Machnik</surname><given-names>A</given-names></name><name><surname>Dahlmann</surname><given-names>A</given-names></name><name><surname>Dietsch</surname><given-names>P</given-names></name><name><surname>Beck</surname><given-names>FX</given-names></name><etal/><article-title>Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats</article-title><source>Am J Physiol Renal Physiol</source><year>2008</year><volume>295</volume><fpage>F1752</fpage><lpage>1763</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00531.2007</pub-id><pub-id pub-id-type="pmid">18842823</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Bellido</surname><given-names>C</given-names></name><name><surname>Lopez-Miranda</surname><given-names>J</given-names></name><name><surname>Blanco-Colio</surname><given-names>LM</given-names></name><name><surname>Perez-Martinez</surname><given-names>P</given-names></name><name><surname>Muriana</surname><given-names>FJ</given-names></name><etal/><article-title>Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>1487</fpage><lpage>1491</lpage><pub-id pub-id-type="pmid">15585759</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Thomsen</surname><given-names>C</given-names></name><name><surname>Rasmussen</surname><given-names>O</given-names></name><name><surname>Lousen</surname><given-names>T</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>Fenselau</surname><given-names>S</given-names></name><etal/><article-title>Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects</article-title><source>Am J Clin Nutr</source><year>1999</year><volume>69</volume><fpage>1135</fpage><lpage>1143</lpage><pub-id pub-id-type="pmid">10357731</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Komiya</surname><given-names>H</given-names></name><name><surname>Tajima</surname><given-names>N</given-names></name><article-title>Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima-media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT)</article-title><source>Endocrine</source><year>2005</year><volume>28</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1385/ENDO:28:2:157</pub-id><pub-id pub-id-type="pmid">16388088</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Zilversmit</surname><given-names>DB</given-names></name><article-title>Atherogenesis: a postprandial phenomenon</article-title><source>Circulation</source><year>1979</year><volume>60</volume><fpage>473</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.60.3.473</pub-id><pub-id pub-id-type="pmid">222498</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>BD</given-names></name><name><surname>Padilla</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Wallace</surname><given-names>JP</given-names></name><article-title>Vascular consequences of a high-fat meal in physically active and inactive adults</article-title><source>Appl Physiol Nutr Metab</source><year>2011</year><volume>36</volume><fpage>368</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1139/h11-028</pub-id><pub-id pub-id-type="pmid">21574775</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Cortner</surname><given-names>JA</given-names></name><name><surname>Le</surname><given-names>NA</given-names></name><name><surname>Coates</surname><given-names>PM</given-names></name><name><surname>Bennett</surname><given-names>MJ</given-names></name><name><surname>Cryer</surname><given-names>DR</given-names></name><article-title>Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins</article-title><source>Eur J Clin Invest</source><year>1992</year><volume>22</volume><fpage>158</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2362.1992.tb01821.x</pub-id><pub-id pub-id-type="pmid">1582440</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Bozzetto</surname><given-names>L</given-names></name><name><surname>Annuzzi</surname><given-names>G</given-names></name><name><surname>Corte</surname><given-names>GD</given-names></name><name><surname>Patti</surname><given-names>L</given-names></name><name><surname>Cipriano</surname><given-names>P</given-names></name><etal/><article-title>Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes</article-title><source>Atherosclerosis</source><year>2011</year><volume>217</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2011.03.012</pub-id><pub-id pub-id-type="pmid">21481394</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Glasser</surname><given-names>SP</given-names></name><name><surname>Oberman</surname><given-names>A</given-names></name><name><surname>Kabagambe</surname><given-names>EK</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><etal/><article-title>High-fat meal effect on LDL, HDL, and VLDL particle size and number in the genetics of lipid-lowering drugs and diet network (GOLDN): an interventional study</article-title><source>Lipids Health Dis</source><year>2011</year><volume>10</volume><fpage>181</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-181</pub-id><pub-id pub-id-type="pmid">22008512</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Luft</surname><given-names>FC</given-names></name><name><surname>Zemel</surname><given-names>MB</given-names></name><name><surname>Sowers</surname><given-names>JA</given-names></name><name><surname>Fineberg</surname><given-names>NS</given-names></name><name><surname>Weinberger</surname><given-names>MH</given-names></name><article-title>Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man</article-title><source>J Hypertens</source><year>1990</year><volume>8</volume><fpage>663</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1097/00004872-199007000-00010</pub-id><pub-id pub-id-type="pmid">2168457</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Fiorucci</surname><given-names>S</given-names></name><name><surname>Bosso</surname><given-names>R</given-names></name><name><surname>Morelli</surname><given-names>A</given-names></name><article-title>Duodenal osmolality drives gallbladder emptying in humans</article-title><source>Dig Dis Sci</source><year>1990</year><volume>35</volume><fpage>698</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1007/BF01540170</pub-id><pub-id pub-id-type="pmid">2344803</pub-id></mixed-citation></ref></ref-list></back></article>